BerandaBCRX • NASDAQ
add
BioCryst Pharmaceuticals Inc
$7,60
Setelah Jam Perdagangan Normal:(0,00%)0,00
$7,60
Tutup: 22 Nov, 18.41.45 GMT-5 · USD · NASDAQ · Pernyataan Penyangkalan
Tutup sebelumnya
$7,49
Rentang hari
$7,42 - $7,66
Rentang tahun
$4,03 - $8,88
Kapitalisasi pasar
1,57Â M USD
Volume Rata-Rata
2,19Â jt
Rasio P/E
-
Hasil dividen
-
Bursa utama
NASDAQ
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 117,08Â jt | 34,98% |
Biaya operasional | 65,08Â jt | 28,50% |
Laba bersih | -14,03Â jt | 61,18% |
Margin laba bersih | -11,99 | 71,23% |
Penghasilan per saham | -0,07 | 63,16% |
EBITDA | 8,00Â jt | 169,59% |
Tarif pajak efektif | -4,36% | — |
Neraca
Total aset
Total liabilitas
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 330,01Â jt | -17,00% |
Total aset | 491,25Â jt | -6,06% |
Total liabilitas | 959,82Â jt | 2,77% |
Total ekuitas | -468,56 jt | — |
Saham yang beredar | 207,13 jt | — |
Harga terhadap nilai buku | -3,31 | — |
Tingkat pengembalian aset | 3,99% | — |
Tingkat pengembalian modal | 5,14% | — |
Arus Kas
Perubahan kas bersih
| (USD) | Sep 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -14,03Â jt | 61,18% |
Kas dari operasi | 8,24Â jt | 141,44% |
Kas dari investasi | 8,49Â jt | -63,28% |
Kas dari pembiayaan | 1,27Â jt | 4,00% |
Perubahan kas bersih | 18,86Â jt | 301,26% |
Arus kas bebas | 21,40Â jt | 208,07% |
Tentang
BioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. BioCryst's antiviral drug peramivir was approved by FDA in December 2014. It has also been approved in Japan, Korea, and China. Wikipedia
Didirikan
1986
Kantor pusat
Situs
Karyawan
536
